Abstract
Purpose
Combined pulmonary fibrosis and emphysema (CPFE) has recently been reported as a prognostic factor that may increase the risk of lung cancer for patients with respiratory disorders; however, there have been no reports published on mortality and morbidity following major lung resection for patients with CPFE.
Methods
The subjects of this retrospective study were 1507 patients who underwent surgical resection of lung cancer at our institute between 2008 and 2013. We reviewed the computed tomography findings and divided the patients into four groups: CPFE group, fibrosis group, emphysema group, and normal group. The surgical outcomes of the patients with CPFE were compared with those of the patients in the other groups.
Results
The CPFE group comprised 137 (10.0 %) patients. This group had worse surgical morbidity and mortality rates than either the fibrosis group or the emphysema group. The 90-day mortality rates for the CPFE, fibrosis, and emphysema groups were 7.3, 0, and 3.0 %, respectively. A multivariate analysis of the CPFE group revealed that the distribution of IIP (HR 13.29, p = 0.038) and blood loss (ml) (HR 1.001, p = 0.013) predicted the hazard ratio for 90-day mortality.
Conclusions
The postoperative outcome of patients with CPFE in this study was poor with respect to morbidity and mortality. The high rate of complications and poor survival warrants further investigation of the indications for surgery in patients with CPFE.
Similar content being viewed by others
References
Kudoh S, Kato H, Nishiwaki Y, Fukuoka M, Nakata K, Ichinose Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med. 2008;177:1348–57.
Movsas B, Raffin TA, Epstein AH, Link CJ. Pulmonary radiation injury. Chest. 1997;111:1061–76.
Takeyuki Makimoto ST, Kazushige Hayakawa, Ryusei Saitoh, Masatomo Mori. Risk factors for severe radiation pneumonitis in lung cancer. Jpn J Clin Oncol 1999;29:192–97.
Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26:586–93.
Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012;141:222–31.
Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. American College of Chest P. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132:161S–77S.
Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 2013.
Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652–8.
Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136:10–5.
Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 2009;103:1209–15.
Kwak N, Park CM, Lee J, Park YS, Lee SM, Yim JJ, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med. 2014;108:524–30.
Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010;15:265–71.
Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology. 2011;16:326–31.
Papiris SA, Triantafillidou C, Manali ED, Kolilekas L, Baou K, Kagouridis K, et al. Combined pulmonary fibrosis and emphysema. Expert Rev Resp Med 2013;7:19–31 (quiz 32).
Minegishi Y, Kokuho N, Miura Y, Matsumoto M, Miyanaga A, Noro R, et al. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema. Lung Cancer. 2014;85:258–63.
Girard Nicolas, Marchand-Adam Sylvain, Naccache Jean-Marc, Borie Raphael, Urban Thierry, Jouneau Stephane, et al. Lung cancer in combined pulmonary fibrosis and emphysema A series of 47 western patient. J Thorac Oncol. 2014;9:1162–70.
Acknowledgments
This study was supported in part by the National Cancer Center Research and Development Fund (26-A-4). We thank the doctors working in respiratory medicine and anesthesiology at Juntendo University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Mariko Fukui and the other co-authors have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Fukui, M., Suzuki, K., Matsunaga, T. et al. Outcomes of lung cancer resection for patients with combined pulmonary fibrosis and emphysema. Surg Today 46, 341–347 (2016). https://doi.org/10.1007/s00595-015-1234-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-015-1234-z